Floatz logo

FENTANYL

Systemic Inflammatory Response Syndrome

University of CreteSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Systemic Inflammatory Response Syndrome cohort.

Asset / SponsorPhaseRating
Rocuronium
University of Crete
Phase 4BB
MAGNESIUM METALLICUM
University of Crete
Phase 4BB
LIDOCAINE
University of Crete
Phase 4BB
CISATRACURIUM ION
University of Crete
Phase 4BB
DROPERIDOL
University of Crete
Phase 4BB

View all 18 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →